APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 281 filers reported holding APELLIS PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.61 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $382,711 | -85.8% | 4,201 | -89.7% | 0.00% | -100.0% |
| Q1 2023 | $2,687,738 | -6.3% | 40,748 | -26.6% | 0.00% | -33.3% |
| Q4 2022 | $2,869,802 | -5.2% | 55,498 | +25.2% | 0.00% | 0.0% |
| Q3 2022 | $3,028,000 | +52.0% | 44,334 | +0.7% | 0.00% | +50.0% |
| Q2 2022 | $1,992,000 | -6.4% | 44,044 | +5.1% | 0.00% | 0.0% |
| Q1 2022 | $2,129,000 | -54.5% | 41,906 | -58.6% | 0.00% | -50.0% |
| Q4 2021 | $4,680,000 | +121.2% | 101,123 | +57.5% | 0.00% | +100.0% |
| Q3 2021 | $2,116,000 | – | 64,196 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AJU IB Investment Co., Ltd. | 1,114,962 | $63,776,000 | 24.13% |
| Octagon Capital Advisors LP | 548,374 | $31,367,000 | 10.87% |
| Ghost Tree Capital, LLC | 325,000 | $18,590,000 | 4.14% |
| Burrage Capital Management LLC | 81,357 | $4,654,000 | 3.55% |
| Aufman Associates Inc | 53,642 | $3,068,000 | 2.75% |
| ACUTA CAPITAL PARTNERS, LLC | 167,054 | $9,555,000 | 2.60% |
| Cormorant Asset Management, LP | 1,866,108 | $106,741,000 | 2.54% |
| Tri Locum Partners LP | 121,409 | $6,945,000 | 2.52% |
| venBio Partners LLC | 490,471 | $28,055,000 | 2.48% |
| HHLR ADVISORS, LTD. | 5,028,289 | $287,618,000 | 2.29% |